These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Influence of enantiomers of 1-naphthylalanine in position 2 of VAVP and dVAVP on their pharmacological properties. Derdowska I; Prahl A; Kowalczyk W; Janecki M; Melhem S; Trzeciak HI; Lammek B Eur J Med Chem; 2005 Jan; 40(1):63-8. PubMed ID: 15642410 [TBL] [Abstract][Full Text] [Related]
24. Novel approach to the design of synthetic radioiodinated linear V1A receptor antagonists of vasopressin. Manning M; Bankowski K; Barberis C; Jard S; Elands J; Chan WY Int J Pept Protein Res; 1992; 40(3-4):261-7. PubMed ID: 1478783 [TBL] [Abstract][Full Text] [Related]
25. Isosteric substitution of Asn5 in antagonists of oxytocin and vasopressin leads to highly selective and potent oxytocin and V1a receptor antagonists: new approaches for the design of potential tocolytics for preterm labor. Chan WY; Wo NC; Cheng LL; Manning M J Pharmacol Exp Ther; 1996 May; 277(2):999-1003. PubMed ID: 8627583 [TBL] [Abstract][Full Text] [Related]
26. Solution structure of conformationally restricted vasopressin analogues. Trzepałka E; Oleszczuk M; Maciejczyk M; Lammek B Acta Biochim Pol; 2004; 51(1):33-49. PubMed ID: 15094823 [TBL] [Abstract][Full Text] [Related]
27. Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4. Cheng LL; Stoev S; Manning M; Derick S; Pena A; Mimoun MB; Guillon G J Med Chem; 2004 Apr; 47(9):2375-88. PubMed ID: 15084136 [TBL] [Abstract][Full Text] [Related]
28. Design of potent and selective linear antagonists of vasopressor (V1-receptor) responses to vasopressin. Manning M; Stoev S; Kolodziejczyk A; Klis WA; Kruszynski M; Misicka A; Olma A; Wo NC; Sawyer WH J Med Chem; 1990 Nov; 33(11):3079-86. PubMed ID: 2231609 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and binding properties of cyclohexapeptide somatostatin analogs containing naphthylalanine and arylalkyl peptoid residues. Tran TA; Mattern RH; Morgan BA; Taylor JE; Goodman M J Pept Sci; 1999 Mar; 5(3):113-30. PubMed ID: 10323556 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and some pharmacological properties of potent and selective antagonists of the vasopressor (V1-receptor) response to arginine-vasopressin. Manning M; Stoev S; Bankowski K; Misicka A; Lammek B; Wo NC; Sawyer WH J Med Chem; 1992 Jan; 35(2):382-8. PubMed ID: 1531076 [TBL] [Abstract][Full Text] [Related]
31. Design and synthesis of potent, highly selective vasopressin hypotensive agonists. Stoev S; Cheng LL; Manning M; Wo NC; Szeto HH J Pept Sci; 2006 Sep; 12(9):592-604. PubMed ID: 16625682 [TBL] [Abstract][Full Text] [Related]
32. Novel linear antagonists of the antidiuretic (V2) and vasopressor (V1) responses to vasopressin. Manning M; Klis WA; Kruszynski M; Przybylski JP; Olma A; Wo NC; Pelton GH; Sawyer WH Int J Pept Protein Res; 1988 Dec; 32(6):455-67. PubMed ID: 3246475 [TBL] [Abstract][Full Text] [Related]
35. Position 4 analogues of [deamino-Cys(1)] arginine vasopressin exhibit striking species differences for human and rat V(2)/V(1b) receptor selectivity. Guillon G; Pena A; Murat B; Derick S; Trueba M; Ventura MA; Szeto HH; Wo N; Stoev S; Cheng LL; Manning M J Pept Sci; 2006 Mar; 12(3):190-8. PubMed ID: 16130178 [TBL] [Abstract][Full Text] [Related]
36. Influence of conformationally constrained amino acids replacing positions 2 and 3 of arginine vasopressin (AVP) and its analogues on their pharmacological properties. Sobolewski D; Prahl A; Derdowska I; Kwiatkowska A; Slaninová J; Lammek B Protein Pept Lett; 2007; 14(3):213-7. PubMed ID: 17346223 [TBL] [Abstract][Full Text] [Related]
37. Proton NMR conformational analysis of cyclic beta-casomorphin analogues of the type Tyr-cyclo[N omega-D-Orn-Xaa-Yaa-Gly-]. Mrestani-Klaus C; Brandt W; Schmidt R; Neubert K; Schiller PW Arch Pharm (Weinheim); 1996 Mar; 329(3):133-42. PubMed ID: 9005812 [TBL] [Abstract][Full Text] [Related]
38. Identification and characterization of two classes of receptors for oxytocin and vasopressin in porcine tunica albuginea, epididymis, and vas deferens. Maggi M; Malozowski S; Kassis S; Guardabasso V; Rodbard D Endocrinology; 1987 Mar; 120(3):986-94. PubMed ID: 3026794 [TBL] [Abstract][Full Text] [Related]
39. Pharmacological characterization of V1a vasopressin receptors in the rat cortical collecting duct. Ammar A; Roseau S; Butlen D Am J Physiol; 1992 Apr; 262(4 Pt 2):F546-53. PubMed ID: 1533099 [TBL] [Abstract][Full Text] [Related]
40. Conformational studies of vasopressin analogues modified with N-methylphenylalanine enantiomers in dimethyl sulfoxide solution. Sikorska E; Slusarz MJ; Lammek B Biopolymers; 2006 Aug; 82(6):603-14. PubMed ID: 16557499 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]